NL-OMON23328
Completed
Not Applicable
A Magnetic Resonance Spectroscopy (MRS) study to explore the effects of a medical food on brain metabolites in patients with mild Alzheimer's Disease Dementia (AD).
Danone Research ¨C Centre for Specialised Nutrition0 sites30 target enrollmentTBD
ConditionsAlzheimer¡¯s Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Alzheimer¡¯s Disease
- Sponsor
- Danone Research ¨C Centre for Specialised Nutrition
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Results published in 'Alzheimer's Research & Therapy', website: https://doi.org/10.1186/s13195-017-0286-2
Investigators
Eligibility Criteria
Inclusion Criteria
- •Main inclusion criteria:
- •1\. Diagnosis of probable or possible AD with evidence of the pathophysiological process according to the recently revised criteria;
Exclusion Criteria
- •Main exclusion criteria:
- •1\. Diagnosis of significant neurological and/or psychiatric disease other than AD;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Not Applicable
MRS and Medication Response: A Pilot StudyMajor Depressive DisorderMajor Depressive EpisodeMajor Depressive Disorder, RecurrentMajor Depression MildMajor Depression ModerateMajor Depression SevereNCT03254342Stanford University3
Unknown
Not Applicable
MRS and DTI of White Matter in Alzheimer's DiseaseAlzheimer's DiseaseVascular DementiaNCT00172900National Taiwan University Hospital40
Unknown
Not Applicable
Imaging of New Learning in Severe Alzheimer's Disease PatientsAlzheimer DiseaseNCT01839422University Hospital, Caen60
Withdrawn
Not Applicable
A Composite MR Neuroimaging Marker for Alzheimer's DiseaseAlzheimer's DiseaseMild Cognitive ImpairmentFrontotemporal DementiaNCT01615666Medical College of Wisconsin
Completed
Phase 4
Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's DiseaseAlzheimer's DiseaseNCT00933608NYU Langone Health17